SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
SanBio SG&A Expense (Quarterly): 1.851M for April 30, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2024 | 1.851M |
| January 31, 2024 | 2.813M |
| October 31, 2023 | 2.072M |
| July 31, 2023 | 4.003M |
| April 30, 2023 | 3.099M |
| January 31, 2023 | 2.648M |
| October 31, 2022 | 2.980M |
| July 31, 2022 | 3.964M |
| April 30, 2022 | 3.958M |
| January 31, 2022 | 4.130M |
| October 31, 2021 | 3.533M |
| July 31, 2021 | 3.529M |
| April 30, 2021 | 3.840M |
| January 31, 2021 | 4.966M |
| October 31, 2020 | 4.181M |
| July 31, 2020 | 3.612M |
| April 30, 2020 | 3.550M |
| January 31, 2020 | 3.800M |
| October 31, 2019 | 3.651M |
| Date | Value |
|---|---|
| July 31, 2019 | 4.201M |
| April 30, 2019 | 3.086M |
| January 31, 2019 | 1.825M |
| October 31, 2018 | 1.687M |
| July 31, 2018 | 1.558M |
| April 30, 2018 | 1.775M |
| January 31, 2018 | 1.53M |
| October 31, 2017 | 1.285M |
| July 31, 2017 | 1.623M |
| April 30, 2017 | 1.931M |
| January 31, 2017 | 2.207M |
| October 31, 2016 | 2.021M |
| July 31, 2016 | 1.586M |
| April 30, 2016 | 1.611M |
| January 31, 2016 | 1.375M |
| October 31, 2015 | 1.290M |
| July 31, 2015 | 0.9909M |
| April 30, 2015 | 1.341M |
| January 31, 2015 | 0.9244M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.851M
Minimum
Apr 2024
4.966M
Maximum
Jan 2021
3.519M
Average
3.631M
Median
SG&A Expense (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.922B |
| Nxera Pharma Co Ltd | 24.59M |
| PeptiDream Inc | 12.68M |
| Healios KK | 2.520M |
| AnGes Inc | 10.62M |